HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HENGRUI PHARMA

44.420

-1.180-2.59%

Volume:1.94M

Turnover:86.59M

Market Cap:294.82B

PE:32.17

High:45.500

Open:45.500

Low:44.240

Close:45.600

52wk High:94.869

52wk Low:43.020

Shares:6.64B

HK Float Shares:258.00M

Volume Ratio:0.52

T/O Rate:0.75%

Dividend:0.23

Dividend Rate:0.53%

EPS(LYR):1.381

ROE:12.46%

ROA:7.02%

PB:3.91

PE(LYR):32.17

PS:8.04

Loading ...

Overview Company News Filings

HENGRUI PHARMA Shares Surge Over 4% in Late Trading as China's First Anti-HER2 Product for Colorectal Cancer Gains Market Approval

Movement Alert｜HENGRUI PHARMA Rises 3.1% in Regular Trading, Two Innovative Drugs Approved for New Indications

Hengrui Pharma Unit Gets Marketing Nod for Colorectal Cancer Drug in China

MT Newswires Live

Hengrui Pharma Secures China’s First Anti-HER2 Approval for Colorectal Cancer with Trastuzumab Rezetecan

Bulletin Express

Jiangsu Hengrui Pharmaceuticals - Nmpa Approved Additional (Fifth) Indication for Ivarmacitinib Sulfate Tablets (Shr0302 Tablets)

THOMSON REUTERS

Jiangsu Hengrui Pharmaceuticals - Nmpa Approves Third Indication for Trastuzumab Rezetecan for Injection for Marketing in China

THOMSON REUTERS

JAK1 Inhibitor Aisuda Secures Fifth Indication Approval for Active Non-Radiographic Axial Spondyloarthritis

Jiangsu Hengrui Pharmaceuticals Secures Approval for Third Indication of Its Anti-HER2 Injection

Citigroup’s Long Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Increases to 5.06% on July 31 from 4.46% - HKEX Filing

THOMSON REUTERS

HENGRUI PHARMA's Zhang Lianshan: Global Strategy at a Turning Point, Innovative Drug Firms Must Ultimately Go Global Independently

Movement Alert｜HENGRUI PHARMA Falls 3.09% in Regular Trading, Trading at HK$56.35

Cross-Market Valuation Disparities: Top A-H Share Premium Rankings as of August 5th

Hengrui Pharmaceuticals Gets China Nod for Lung Cancer Combo Trials

MT Newswires Live

Hengrui Pharma Completes 13.75 Million Share Buyback as of July 31

HENGRUI PHARMA's Subsidiary Secures Approval for Clinical Trial Initiation

Hengrui Pharma Maintains Stable H-Share Base; Repurchases 0.28 Million A-Shares in July

Bulletin Express

Dual-Listed Stock Premium Snapshot: August 3 Market Close

Metis TechBio Jumps on Jiangsu Hengrui-tie up on AI Formulation Platform

METIS TECHBIO-P Deploys AI Drug Formulation Platform at HENGRUI PHARMA, Accelerating NanoForge Commercialization

The Capital Group Companies Increases Stake in Hengrui Pharma with 483,600 Share Purchase at Approximately HK$57.90 Each

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/01276/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"01276","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","market":"HK","secType":"STK","nameCN":"HENGRUI PHARMA","latestPrice":44.42,"timestamp":1789632489005,"preClose":45.6,"halted":0,"volume":1936525,"delay":0,"changeRate":-0.025877192982456134,"floatShares":258000000,"shares":6637000000,"eps":1.38093615886142,"marketStatus":"Closed","change":-1.18,"latestTime":"09-17 16:08:09","open":45.5,"high":45.5,"low":44.24,"amount":86589646,"amplitude":0.027632,"askPrice":44.46,"askSize":3400,"bidPrice":44.42,"bidSize":12600,"shortable":3,"etf":0,"ttmEps":1.361848812462242,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789695000000},"marketStatusCode":5,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":45.6,"dividendRate":0.005253,"openAndCloseTimeList":[[1789608600000,1789617600000],[1789621200000,1789632000000]],"volumeRatio":0.518853,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600276","market":"SH","secType":"STK","nameCN":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.","latestPrice":43.23,"timestamp":1789628400000,"preClose":43.52,"halted":0,"volume":35252300,"delay":0,"premium":"-12.20"}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","floatShares":258000000,"roa":"7.02%","roe":"12.46%","lyrEps":1.380936,"volumeRatio":0.518853,"shares":6637000000,"dividePrice":0.234057,"high":45.5,"amplitude":0.027632,"preClose":45.6,"low":44.24,"week52Low":43.02,"pbRate":"3.91","psRate":"8.04","week52High":94.869,"institutionHeld":0,"latestPrice":44.42,"committee":0.575,"eps":1.38093615886142,"divideRate":0.005269,"volume":1936525,"delay":0,"ttmEps":1.361848812462242,"open":45.5,"prevYearClose":71.002,"prevWeekClose":43.76,"prevMonthClose":46.06,"prevQuarterClose":57.85,"fiveDayClose":43.96,"twentyDayClose":49.66,"sixtyDayClose":56.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01276\",params:#limit:5,,,undefined,":[{"date":"2026-08-19","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787103000000,"name":null,"time":"","dateTimestamp":1787068800000,"actualEps":null},{"date":"2026-04-29","symbol":"01276","amount":0.22828,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2026-04-30","defaultRemindTime":1777426200000,"name":"恒瑞医药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-27","payableDate":"2026-04-30","currency":"HKD","dateTimestamp":1777392000000,"payDate":"2026-05-27"},{"date":"2026-04-22","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1776821400000,"name":null,"time":"","dateTimestamp":1776787200000,"actualEps":null},{"date":"2026-03-26","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774488600000,"name":null,"time":"","dateTimestamp":1774454400000,"actualEps":null},{"date":"2025-10-28","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1761615000000,"name":null,"time":"","dateTimestamp":1761580800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01276\",market:\"HK\",,,undefined,":[{"executeDate":"2026-04-29","recordDate":"2026-04-30","paymentDate":"2026-05-27","value":0.22828,"currency":"HKD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01276\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2727,"buy":0.5455,"hold":0.1818,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5455,"analysts":11,"updateTime":1786723200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01276\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01276","date":"2026-09-16","current":32.635261,"percent":0.01227,"low":36.382401,"twenty":43.825898,"median":51.677932,"eighty":56.983927,"high":65.582363,"avg":51.073535,"sd":7.480955,"marketCap":335564360039.49},"quantilePoints":[{"date":"2025-05-23","current":52.570963,"twenty":52.783176,"median":53.101495,"eighty":53.419815,"marketCap":390693388207.53},{"date":"2025-05-30","current":53.015805,"twenty":51.822085,"median":52.540895,"eighty":52.926837,"marketCap":395731540422.24},{"date":"2025-06-06","current":52.120101,"twenty":52.130014,"median":52.555929,"eighty":53.075252,"marketCap":390038198012.59},{"date":"2025-06-13","current":52.209491,"twenty":52.177631,"median":52.691227,"eighty":53.357137,"marketCap":390861633032.23},{"date":"2025-06-20","current":50.172412,"twenty":51.591196,"median":52.469796,"eighty":53.075252,"marketCap":374874997562.85},{"date":"2025-06-27","current":50.314776,"twenty":50.363569,"median":52.169666,"eighty":53.013533,"marketCap":376991477472.78},{"date":"2025-07-04","current":51.666141,"twenty":50.343584,"median":52.120101,"eighty":53.004446,"marketCap":387134991658.26},{"date":"2025-07-11","current":55.507007,"twenty":50.44351,"median":52.13337,"eighty":53.090114,"marketCap":415495681161.23},{"date":"2025-07-18","current":57.272274,"twenty":50.582121,"median":52.209491,"eighty":54.057606,"marketCap":428373566715.29},{"date":"2025-07-25","current":54.897923,"twenty":50.594414,"median":52.555929,"eighty":55.711415,"marketCap":412107620053.2},{"date":"2025-08-01","current":59.731878,"twenty":50.855059,"median":52.994419,"eighty":55.972407,"marketCap":445624526286.47},{"date":"2025-08-08","current":59.478715,"twenty":51.107295,"median":53.05296,"eighty":56.541585,"marketCap":444845815775.64},{"date":"2025-08-15","current":61.917611,"twenty":51.356483,"median":53.519848,"eighty":59.478715,"marketCap":462392609292.46},{"date":"2025-08-22","current":58.782188,"twenty":51.569512,"median":54.477764,"eighty":60.15932,"marketCap":470428104569.66},{"date":"2025-08-29","current":59.85298,"twenty":51.666141,"median":55.691374,"eighty":59.937003,"marketCap":481284287403.35},{"date":"2025-09-05","current":65.582363,"twenty":51.677932,"median":55.770266,"eighty":60.732448,"marketCap":526832269752.24},{"date":"2025-09-12","current":62.481332,"twenty":51.8337,"median":55.972407,"eighty":61.285609,"marketCap":502824785657.99},{"date":"2025-09-19","current":63.179889,"twenty":52.120101,"median":56.254853,"eighty":61.852995,"marketCap":508085671393.42},{"date":"2025-09-26","current":63.528382,"twenty":52.146639,"median":56.965096,"eighty":62.270337,"marketCap":509562668601.01},{"date":"2025-10-03","current":64.989073,"twenty":52.165061,"median":57.272274,"eighty":62.504861,"marketCap":522523002865.02},{"date":"2025-10-10","current":61.782766,"twenty":52.193561,"median":59.039802,"eighty":62.657943,"marketCap":496019912951.91},{"date":"2025-10-17","current":58.903713,"twenty":52.323014,"median":59.170669,"eighty":62.619084,"marketCap":472537436949.31},{"date":"2025-10-24","current":59.187086,"twenty":52.484015,"median":59.039802,"eighty":62.52839,"marketCap":474983377696.11},{"date":"2025-10-31","current":57.072441,"twenty":52.552922,"median":59.021138,"eighty":62.417499,"marketCap":465758305542.93},{"date":"2025-11-07","current":54.713071,"twenty":52.619069,"median":58.881843,"eighty":62.304573,"marketCap":446224987036.64},{"date":"2025-11-14","current":55.883072,"twenty":52.812504,"median":58.231971,"eighty":62.27542,"marketCap":457058673340.29},{"date":"2025-11-21","current":52.805265,"twenty":52.880927,"median":57.030538,"eighty":62.209511,"marketCap":431684582485.14},{"date":"2025-11-28","current":55.237621,"twenty":52.99843,"median":56.630614,"eighty":62.069705,"marketCap":453209419829.34},{"date":"2025-12-05","current":54.841023,"twenty":53.00899,"median":56.437545,"eighty":61.965159,"marketCap":450729029423.46},{"date":"2025-12-12","current":56.212257,"twenty":53.045529,"median":56.385682,"eighty":61.891765,"marketCap":462853512587.19},{"date":"2025-12-19","current":54.083493,"twenty":53.045529,"median":56.227363,"eighty":61.831221,"marketCap":446374731108.34},{"date":"2025-12-24","current":54.414957,"twenty":53.090114,"median":56.103073,"eighty":61.798561,"marketCap":450509359276.9},{"date":"2026-01-02","current":53.078544,"twenty":53.065996,"median":55.972407,"eighty":61.785925,"marketCap":441174507319.22},{"date":"2026-01-09","current":56.743223,"twenty":53.0878,"median":56.0944,"eighty":61.695241,"marketCap":472808676524.34},{"date":"2026-01-16","current":55.187351,"twenty":53.304215,"median":56.103073,"eighty":61.405393,"marketCap":461338821289.95},{"date":"2026-01-23","current":52.546341,"twenty":53.0878,"median":56.076447,"eighty":61.296167,"marketCap":438839874056.97},{"date":"2026-01-30","current":51.677141,"twenty":52.994149,"median":55.908509,"eighty":61.278475,"marketCap":433553740508.2},{"date":"2026-02-06","current":50.918226,"twenty":52.680723,"median":55.839154,"eighty":61.101743,"marketCap":428270226283.58},{"date":"2026-02-13","current":51.771686,"twenty":52.512455,"median":55.711415,"eighty":60.890064,"marketCap":437949787160.49},{"date":"2026-02-20","current":51.752043,"twenty":52.351169,"median":55.691374,"eighty":60.824953,"marketCap":437153052005.04},{"date":"2026-02-27","current":50.215456,"twenty":52.151244,"median":55.507566,"eighty":60.720339,"marketCap":428825318404.97},{"date":"2026-03-06","current":49.335298,"twenty":51.80347,"median":55.280584,"eighty":60.654676,"marketCap":417912584744.19},{"date":"2026-03-13","current":48.90444,"twenty":51.75217,"median":55.201025,"eighty":60.572606,"marketCap":416170839186.33},{"date":"2026-03-20","current":48.948437,"twenty":51.671435,"median":55.086674,"eighty":60.515374,"marketCap":414967977646.95},{"date":"2026-03-27","current":47.483832,"twenty":51.400677,"median":54.94883,"eighty":60.443129,"marketCap":414588875872.42},{"date":"2026-04-02","current":49.302243,"twenty":51.107295,"median":54.905743,"eighty":60.227005,"marketCap":432534434303.11},{"date":"2026-04-10","current":49.055344,"twenty":50.995993,"median":54.897923,"eighty":60.186394,"marketCap":433687668394.36},{"date":"2026-04-17","current":48.417764,"twenty":50.589497,"median":54.65026,"eighty":60.143018,"marketCap":428230701835.75},{"date":"2026-04-24","current":45.835792,"twenty":50.342877,"median":54.475147,"eighty":60.015062,"marketCap":426879682872.04},{"date":"2026-04-30","current":44.026312,"twenty":50.285416,"median":54.355253,"eighty":59.903394,"marketCap":410132737659.64},{"date":"2026-05-08","current":43.161515,"twenty":50.207478,"median":54.262074,"eighty":59.804539,"marketCap":403472171949.3},{"date":"2026-05-15","current":44.128138,"twenty":49.985706,"median":54.115335,"eighty":59.70386,"marketCap":413593092820.6},{"date":"2026-05-22","current":41.244553,"twenty":49.583265,"median":53.983854,"eighty":59.631568,"marketCap":385683097978.4},{"date":"2026-05-29","current":40.98659,"twenty":49.34142,"median":53.840414,"eighty":59.564678,"marketCap":384603594259.51},{"date":"2026-06-05","current":38.394132,"twenty":49.063316,"median":53.633194,"eighty":59.459458,"marketCap":360799766229.36},{"date":"2026-06-12","current":39.515262,"twenty":48.81081,"median":53.517715,"eighty":59.36625,"marketCap":371084155232.86},{"date":"2026-06-18","current":39.444808,"twenty":48.417764,"median":53.467699,"eighty":59.301536,"marketCap":371311256576.18},{"date":"2026-06-26","current":39.60241,"twenty":47.951326,"median":53.090114,"eighty":59.187086,"marketCap":370974287810.31},{"date":"2026-07-03","current":44.319925,"twenty":47.638943,"median":53.015805,"eighty":59.069259,"marketCap":415476044901.86},{"date":"2026-07-10","current":45.319748,"twenty":47.348429,"median":52.993744,"eighty":59.024871,"marketCap":424327469311.14},{"date":"2026-07-17","current":43.189222,"twenty":46.151454,"median":52.805265,"eighty":58.96135,"marketCap":405818502739.33},{"date":"2026-07-24","current":43.433009,"twenty":45.632553,"median":52.604835,"eighty":58.912251,"marketCap":408200902707.63},{"date":"2026-07-31","current":43.935338,"twenty":45.29749,"median":52.543618,"eighty":58.877468,"marketCap":413706414238.87},{"date":"2026-08-07","current":44.394532,"twenty":45.008473,"median":52.339287,"eighty":58.813302,"marketCap":418841988303.56},{"date":"2026-08-14","current":42.6704,"twenty":44.628794,"median":52.189578,"eighty":58.452058,"marketCap":403085247281.44},{"date":"2026-08-21","current":40.686911,"twenty":44.408765,"median":52.120101,"eighty":57.75211,"marketCap":366558497066.13},{"date":"2026-08-28","current":40.334802,"twenty":44.24321,"median":51.814807,"eighty":57.336246,"marketCap":363468645736.13},{"date":"2026-09-04","current":39.220129,"twenty":44.050964,"median":51.771686,"eighty":57.152374,"marketCap":353565883607.49},{"date":"2026-09-11","current":36.382401,"twenty":43.912617,"median":51.717719,"eighty":57.022157,"marketCap":328426636361.34},{"date":"2026-09-16","current":37.134263,"twenty":43.825898,"median":51.677932,"eighty":56.983927,"marketCap":335564360039.49}],"updateTime":1789642357909},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01276\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1177922465","title":"HENGRUI PHARMA Shares Surge Over 4% in Late Trading as China's First Anti-HER2 Product for Colorectal Cancer Gains Market Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1177922465","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177922465?lang=en_us&edition=fundamental","pubTime":"2026-08-07 15:24","pubTimestamp":1786087459,"startTime":"0","endTime":"0","summary":"HENGRUI PHARMA (01276) shares climbed more than 4% in late trading, currently up 3.9% to HK$58.6, with a trading volume of HK$220 million. On August 6, the company announced that the third indication...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2148510915.USD","LU2289578879.USD","LU0405327148.USD","LU2097828631.EUR","LU0359202008.SGD","LU1255011170.USD","LU2495084118.USD","BK0188","BK0060","LU1328615791.USD","LU1064131003.USD","BK1191","LU0359201885.HKD","LU1023057109.AUD","LU2097828557.USD","LU1580142542.USD","BK0183","LU2580892789.USD","LU1997244956.HKD","BK0012","IPOS","LU2097828805.USD","LU1969619763.USD","BK0028","LU2488822045.USD","VXUS","LU0359201612.USD","LU1997245177.USD","BK4588","LU2543165471.USD","LU1146622755.USD","LU2097828714.EUR","LU0405327494.USD","KCAI","LU1655091616.SGD","LU2580892862.HKD","LU2328871848.SGD","BK0196","LU1781817850.SGD","600276","01276","BK0239","LU1997245094.SGD","LU1064130708.USD","LU1820825898.SGD","LU2097828474.EUR","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185344761","title":"Movement Alert｜HENGRUI PHARMA Rises 3.1% in Regular Trading, Two Innovative Drugs Approved for New Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=1185344761","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185344761?lang=en_us&edition=fundamental","pubTime":"2026-08-07 13:21","pubTimestamp":1786080078,"startTime":"0","endTime":"0","summary":"On August 7, HENGRUI PHARMA rose 3.1% in regular trading, trading at HKD 57.9/share, with turnover of HKD 131 million.The rally was primarily driven by the simultaneous approval of two innovative...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657634143","title":"Hengrui Pharma Unit Gets Marketing Nod for Colorectal Cancer Drug in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2657634143","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657634143?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:54","pubTimestamp":1786020887,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  unit Suzhou Suncadia Biopharmaceuticals' third indication for trastuzumab rezetecan for injection was approved for marketing by China's National Medical Products Administration.The drug is now the first anti-HER2 product approved for the treatment of colorectal cancer in China.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0359201885.HKD","LU0359202008.SGD","LU1023057109.AUD","01276","LU2543165471.USD","LU0359201612.USD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165330909","title":"Hengrui Pharma Secures China’s First Anti-HER2 Approval for Colorectal Cancer with Trastuzumab Rezetecan","url":"https://stock-news.laohu8.com/highlight/detail?id=1165330909","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165330909?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:44","pubTimestamp":1786020250,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma, 01276) has received National Medical Products Administration (NMPA) clearance for a third indication of its in-house developed antibody-drug...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657631627","title":"Jiangsu Hengrui Pharmaceuticals - Nmpa Approved Additional (Fifth) Indication for Ivarmacitinib Sulfate Tablets (Shr0302 Tablets)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657631627","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657631627?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:40","pubTimestamp":1786020015,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nFWN4430WZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2097828474.EUR","LU2289578879.USD","LU2580892862.HKD","LU1781817850.SGD","LU2097828805.USD","BK1191","LU2097828714.EUR","LU1023057109.AUD","LU1997245177.USD","LU2097828557.USD","BK0060","LU1997244956.HKD","LU0405327148.USD","BK0188","BK0028","LU2328871848.SGD","LU2148510915.USD","LU0405327494.USD","BK0239","LU1064131003.USD","LU1820825898.SGD","LU0359201612.USD","LU2543165471.USD","BK0012","LU0359202008.SGD","LU1064130708.USD","LU2580892789.USD","LU0359201885.HKD","LU1655091616.SGD","LU1969619763.USD","LU1146622755.USD","BK0183","LU2097828631.EUR","LU1255011170.USD","LU2495084118.USD","01276","BK0196","LU1997245094.SGD","LU1580142542.USD","LU1328615791.USD","LU2488822045.USD","600276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657327631","title":"Jiangsu Hengrui Pharmaceuticals - Nmpa Approves Third Indication for Trastuzumab Rezetecan for Injection for Marketing in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2657327631","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657327631?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:34","pubTimestamp":1786019685,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nFWN44319M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1580142542.USD","BK1191","LU1146622755.USD","LU2543165471.USD","BK0183","01276","LU2097828714.EUR","BK0028","LU0405327148.USD","LU2097828557.USD","LU2148510915.USD","LU2097828474.EUR","600276","BK0196","LU2488822045.USD","LU2097828805.USD","BK0188","LU1781817850.SGD","LU1997245094.SGD","LU2097828631.EUR","BK0060","LU1255011170.USD","LU1969619763.USD","LU2495084118.USD","LU1064131003.USD","LU1328615791.USD","BK0012","LU1820825898.SGD","LU1023057109.AUD","BK0239","LU1997245177.USD","LU0359201612.USD","LU0359201885.HKD","LU0359202008.SGD","LU2580892862.HKD","LU1655091616.SGD","LU1997244956.HKD","LU2328871848.SGD","LU2289578879.USD","LU2580892789.USD","LU0405327494.USD","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142719906","title":"JAK1 Inhibitor Aisuda Secures Fifth Indication Approval for Active Non-Radiographic Axial Spondyloarthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=1142719906","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142719906?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:11","pubTimestamp":1786018284,"startTime":"0","endTime":"0","summary":"A pivotal Phase III study has met its primary endpoint, with the Aisuda (ivarmacitinib sulfate) group achieving a 39.7% ASAS40 response rate at 12 weeks, compared to 24.8% in the placebo group...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276","BK1191","BK4202","LU0359201612.USD","LU0359201885.HKD","AS","LU0359202008.SGD","LU1023057109.AUD","LU2543165471.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167903648","title":"Jiangsu Hengrui Pharmaceuticals Secures Approval for Third Indication of Its Anti-HER2 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1167903648","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167903648?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:40","pubTimestamp":1786016414,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd. (600276.SH) has announced that its subsidiary, Suzhou Sundia Biopharmaceuticals Co., Ltd., received approval from the National Medical Products Administration...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828474.EUR","LU2289578879.USD","IPOS","LU2580892862.HKD","LU1781817850.SGD","LU2097828805.USD","BK1191","LU2097828714.EUR","LU1023057109.AUD","LU1997245177.USD","LU2097828557.USD","BK0060","LU1997244956.HKD","LU0405327148.USD","BK0188","BK0028","LU2328871848.SGD","LU2148510915.USD","LU0405327494.USD","BK0239","LU1064131003.USD","LU1820825898.SGD","LU0359201612.USD","LU2543165471.USD","BK0012","LU0359202008.SGD","LU1064130708.USD","LU2580892789.USD","LU0359201885.HKD","LU1655091616.SGD","LU1969619763.USD","LU1146622755.USD","BK0183","LU2097828631.EUR","LU1255011170.USD","LU2495084118.USD","01276","BK0196","LU1997245094.SGD","LU1580142542.USD","LU1328615791.USD","LU2488822045.USD","600276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657031682","title":"Citigroup’s Long Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Increases to 5.06% on July 31 from 4.46% - HKEX Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2657031682","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657031682?lang=en_us&edition=fundamental","pubTime":"2026-08-06 18:30","pubTimestamp":1786012206,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nFWN4430J9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2488822045.USD","BK0196","LU2097828631.EUR","LU2495084118.USD","LU0405327494.USD","LU1328615791.USD","LU0405327148.USD","LU2097828714.EUR","LU1781817850.SGD","LU1969619763.USD","LU2148510915.USD","LU1997244956.HKD","LU2097828474.EUR","LU1255011170.USD","LU2097828805.USD","LU2289578879.USD","600276","LU2580892789.USD","BK0188","LU1997245094.SGD","01276","LU0359201885.HKD","LU1064130708.USD","LU1064131003.USD","LU1820825898.SGD","LU2543165471.USD","BK1191","LU2097828557.USD","LU1580142542.USD","BK0028","LU1146622755.USD","BK0060","LU1997245177.USD","LU0359202008.SGD","LU2328871848.SGD","LU0359201612.USD","BK0183","LU2580892862.HKD","LU1023057109.AUD","LU1655091616.SGD","BK0239","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130856515","title":"HENGRUI PHARMA's Zhang Lianshan: Global Strategy at a Turning Point, Innovative Drug Firms Must Ultimately Go Global Independently","url":"https://stock-news.laohu8.com/highlight/detail?id=1130856515","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130856515?lang=en_us&edition=fundamental","pubTime":"2026-08-06 10:00","pubTimestamp":1785981647,"startTime":"0","endTime":"0","summary":"The life sciences industry is undergoing a significant value reassessment, driven by AI's accelerated entry into clinical settings, a surge in global innovation deals, a shift in medical devices from...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2580892862.HKD","LU1023057109.AUD","159992","LU2580892789.USD","LU1580142542.USD","BK1191","LU2328871848.SGD","LU1820825898.SGD","LU1997245177.USD","LU0359202008.SGD","BK1161","BK0183","LU1781817850.SGD","LU2148510915.USD","LU1655091616.SGD","IBBQ","LU0405327494.USD","LNGR","LU1328615791.USD","LU1997245094.SGD","LU2097828714.EUR","01276","LU2097828557.USD","600276","LU1997244956.HKD","BK0060","LU2488822045.USD","LU2495084118.USD","BK0188","LU0405327148.USD","LU1064131003.USD","BK0028","06978","LU2097828631.EUR","BK0239","LU1064130708.USD","LU0359201612.USD","LU2097828474.EUR","LU2097828805.USD","BK0196","LU2289578879.USD","LU1969619763.USD","BK0012","LU1146622755.USD","LU0359201885.HKD","LU2543165471.USD","MEDX","BK1574","LU1255011170.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183354060","title":"Movement Alert｜HENGRUI PHARMA Falls 3.09% in Regular Trading, Trading at HK$56.35","url":"https://stock-news.laohu8.com/highlight/detail?id=1183354060","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183354060?lang=en_us&edition=fundamental","pubTime":"2026-08-06 10:00","pubTimestamp":1785981643,"startTime":"0","endTime":"0","summary":"On August 6, HENGRUI PHARMA fell 3.09% in regular trading, trading at HK$56.35/share, with turnover of HK$59.01 million.Within the Pharmaceuticals sector where HENGRUI PHARMA belongs, the overall...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138299745","title":"Cross-Market Valuation Disparities: Top A-H Share Premium Rankings as of August 5th","url":"https://stock-news.laohu8.com/highlight/detail?id=1138299745","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138299745?lang=en_us&edition=fundamental","pubTime":"2026-08-05 16:22","pubTimestamp":1785918139,"startTime":"0","endTime":"0","summary":"As of the close on August 5th, the top three positions in the A-H share premium ranking were held by NE ELECTRIC (00042), ZHEJIANG SHIBAO (01057), and SINOPEC SSC (01033), with premiums of 988.71%,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1558","LU0828237510.HKD","LU1807302812.USD","BK1237","LU0630378692.HKD","BK1205","LU0235996351.USD","BK1594","LU0823040885.USD","01635","BK1240","IE00BMCWC346.EUR","LU2097828557.USD","HK0000306701.USD","BK1537","82318","BK1149","LU0348827113.USD","LU0762541174.USD","LU0882747503.HKD","00857","LU1770034418.SGD","IE00BYV24P56.USD","LU1497733631.SGD","00300","LU0315179316.USD","LU0605514214.HKD","LU2242644610.SGD","SG9999014674.SGD","LU0502904849.HKD","LU2543165471.USD","LU0128522157.USD","LU1282649810.SGD","LU0463099449.HKD","LU0039217434.USD","LU1497733557.USD","BK1140","LU1880383440.USD","BK1551","IE00B543WZ88.USD","LU1655091459.SGD","LU0784639295.USD","LU1831875114.USD","LU0589944569.HKD","LU2226246903.HKD","LU0651946864.USD","LU1242518931.SGD","LU0791590937.USD","LU2399975544.HKD","BK1560","LU1961090484.USD","LU1244550221.USD","LU1720050803.USD","LU0878004406.USD","HK0001040143.USD","BK1171","LU0326950275.SGD","BK1610","LU0163747925.USD","SG9999001093.SGD","02218","BK1221","LU0348766576.USD","LU0543330566.HKD","HK0000500386.USD","LU0029875118.USD","IE0003895053.USD","LU0197773673.USD","IE00BPRC5H50.USD","LU1522347837.USD","LU1044876610.USD","LU0516422440.USD","LU0072462343.USD","BK1564","IE00BGHQDM52.EUR","LU0572944931.SGD","00895","LU0441854154.USD","SG9999004220.SGD","LU2153592121.USD","LU0831103253.SGD","LU0856984785.SGD","LU1115378108.SGD","LU0348767384.USD","01033","02768","BK1223","LU1366334651.USD","LU0449509016.USD","LU0328353924.USD","LU0348825331.USD","BK1105","LU0181495838.USD","LU2348773727.SGD","LU0501845795.SGD","LU0054450605.USD","BK1514","BK1507","LU0611395673.USD","LU0831093199.SGD","LU0516423091.SGD","00916","03750","LU0315178854.USD","BK1552","LU0211977185.USD","BK1513","LU0348788117.USD","BK1154","LU0871576103.HKD","LU1481107354.HKD","LU1993786604.SGD","06127","LU2153591404.USD","HK0000151867.HKD","IE00B031HY20.USD","IE00BZ08YR35.GBP","LU0314109678.HKD","LU1366334578.USD","BK1550","LU0516423174.USD","LU0084288322.USD","LU0348805143.USD","02359","LU0561508036.HKD","LU2294711473.HKD","BK1546","LU0588545904.SGD","LU0307460666.USD","LU1328277881.USD","LU1008478684.HKD","LU0164865239.USD","LU1152091168.USD","LU0979878070.USD","HK0000306685.HKD","LU0117844026.USD","LU0348814723.USD","LU1785774172.SGD","00991","06031","LU0173614495.USD","LU0819123356.HKD","LU0455707207.USD","LU0052750758.USD","03143","LU0229945570.USD","LU0254981946.USD","LU0651947912.USD","LU1282648689.USD","LU0348783662.USD","LU1303224171.USD","LU1675838814.USD","LU1244550577.SGD","LU0607220059.USD","LU0797268264.HKD","BK1110","LU0588545490.SGD","00553","LU0149534421.HKD","LU0164872284.USD","LU1820825898.SGD","LU0640798160.USD","01276","LU0106252389.USD","LU1688375341.USD","399300","LU0214875030.USD","LU0196878994.USD","IE00B3M56506.USD","LU2778985437.USD","EWH","02318","LU0293314216.USD","LU1813983027.USD","PAImain","BK1528","02208","LU0140636845.USD","LU1023057109.AUD","LU1969619763.USD","HK0001040168.HKD","LU1046422090.SGD","LU0320764599.SGD","LU0244354667.USD","LU1960683339.HKD","BK1521","LU0819121731.USD","06613","LU0449515922.USD","IE00BQJZWZ67.USD","LU2348774022.SGD","LU0918141887.USD","LU0228659784.USD","LU1880383366.USD","LU2097828631.EUR","HPAD.SI","IE00BF5LJ272.USD","LU0287142896.SGD","BK1116","LU0348735423.USD","LU1719994722.HKD","01108","BK1529","LU0456827905.SGD","LU0672654166.SGD","SG9999000459.SGD","SG9999006597.SGD","IE0031814852.USD","LU0543330483.HKD","LU0588545730.USD","LU0048580855.USD","LU0516422366.SGD","LU0488056044.USD","LU0384037296.USD","LU0823426308.USD","HK0000286598.CNH","BK1135","LU0067412154.USD","SG9999001226.SGD","BK1506","IE0008368742.USD","SG9999003461.SGD","BK1125","LU0880133367.SGD","SG9999002463.SGD","IE0008369823.USD","LU0348816934.USD","LU0918141705.HKD","LU0531971595.HKD","LU0348784397.USD","HK0000320264.USD","LU0359201885.HKD","LU0165289439.USD","LU2097828805.USD","LU2125910500.SGD","01349","LU0588546209.SGD","HK0000252160.HKD","LU0531970944.HKD","LU1634259391.SGD","LU1226287529.USD","LU0043850808.USD","BK1202","LU2293587155.HKD","BK1191","LU1224444064.USD","LU1282651121.HKD","IE00BWDBJ730.SGD","LU0456846285.SGD","LU1105468828.SGD","LU0823426480.USD","LU0630378429.USD","IE00B19Z5X02.USD","LU1146622755.USD","LU0210526637.USD","LU1188198961.HKD","LU2097828474.EUR","LU0862451753.SGD","LU0865486749.SGD","03986","LU0972618739.USD","SGXZ62798434.SGD","LU1211504680.USD","LU1242518857.USD","LU0737861699.HKD","IE00BZ08YS42.EUR","LU1282649067.USD","LU0762540952.USD","LU1769817096.USD","PNGAY","LU0417516902.SGD","LU0359201612.USD","SG9999002828.SGD","HK0000352382.USD","BK1214","LU0431992006.USD","LU0149721374.USD","SG9999011746.SGD","SG9999001903.USD","LU0648948544.HKD","LU0051755006.USD","IE00B0169L03.USD","LU0359202008.SGD","LU0370786039.SGD","LU1224709979.USD","BK1583","LU1808992512.USD","LU0593848301.USD","BK1522","LU1251922891.USD","LU0650527681.SGD","SG9999002562.SGD","LU0675040207.SGD","LU0868486357.SGD","BK1226","IE00BZ08YT58.USD","LU0049853897.USD","BK1163","159982","LU1282651048.USD","BK1231","LU0469268626.HKD","HK0000252152.HKD","LU2476274308.USD","06745","01688","LU1497734951.SGD","LU1051768304.USD","BK1554","SGXZ86797644.SGD","LU2039709279.SGD","LU1515016050.SGD","IE00B5MMRT66.SGD","LU0106959298.USD","LU1282649141.HKD","LU0011963245.USD","LU0828237940.HKD","LU1244550494.USD","03678","IE00BVYPNQ40.USD","BK1607","LU1634259557.SGD","BK1144","601318","00763","BK1184","LU0821914370.USD","LU0072913022.USD","HK0000352291.HKD","LU0228367735.SGD","LU0210527791.USD","02338","LU0231483743.USD","LU0320764755.SGD","LU0540923850.HKD","LU0862451837.USD","LU0878005551.USD","00638","LU1048596156.SGD","LU1048588211.SGD","LU2152927971.USD","00042","LU2424517915.HKD","LU1642822792.SGD","02465","03145","LU0049112450.USD","LU1235295612.USD","LU0762542818.HKD","LU0594300419.USD","02691","LU0417516571.SGD","03968","LU0791591158.USD","LU0197773160.USD","LU1044875133.USD","06655","IE0034224299.USD","LU0890818403.SGD","LU2045819591.USD","LU2476274720.SGD","LU1044874839.SGD","LU0164880469.USD","BK1576","BK1170","01057","LU0594300179.USD","BK1526","LU1152091754.HKD","LU2328871848.SGD","IE0032431581.USD","LU0516422952.EUR","LU0634319403.HKD","HK0000320223.HKD","IE00B031J352.USD","LU2097828714.EUR","BK1147","LU0708995583.HKD","IE00BVYPNP33.GBP","LU1051769294.HKD","BK1141","IE00B29SXG58.USD","LU0348783233.USD","LU0405327494.USD","LU0327786744.USD","LU0417516738.SGD","BK1562","LU1981816686.USD","LU1769817179.HKD","LU0117841782.USD","LU1794554557.SGD","LU0405327148.USD","LU0898667661.SGD","03328","BK1530","01812"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657959193","title":"Hengrui Pharmaceuticals Gets China Nod for Lung Cancer Combo Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2657959193","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657959193?lang=en_us&edition=fundamental","pubTime":"2026-08-05 10:47","pubTimestamp":1785898047,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals (SHA:600276, HKG:1276) obtained China's regulatory approval for Phase Two clinical trials combining SHR-A2009 with Adebrelimab or third-generation EGFR-TKI in non-small cell lung cancer patients, according to a Tuesday aftermarket filing with the Shanghai bourse.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0359201885.HKD","LU0359201612.USD","LU0359202008.SGD","BK1191","LU2543165471.USD","01276","LU1023057109.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185803437","title":"Hengrui Pharma Completes 13.75 Million Share Buyback as of July 31","url":"https://stock-news.laohu8.com/highlight/detail?id=1185803437","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185803437?lang=en_us&edition=fundamental","pubTime":"2026-08-04 18:12","pubTimestamp":1785838339,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd. (SSE: 600276) has disclosed its latest share repurchase progress, revealing that as of July 31, 2026, the company had cumulatively bought back 13.75 million...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1146622755.USD","LU2488822045.USD","BK0060","LU1064130708.USD","LU1781817850.SGD","600276","LU2580892862.HKD","LU1580142542.USD","LU2580892789.USD","BK0028","LU1997244956.HKD","LU0359201612.USD","LU0405327494.USD","LU1064131003.USD","LU1969619763.USD","LU2289578879.USD","LU0359201885.HKD","LU1820825898.SGD","LU2097828805.USD","BK1191","LU2543165471.USD","LU2097828557.USD","LU1328615791.USD","LU1655091616.SGD","BK0188","LU2097828714.EUR","BK0196","LU2097828474.EUR","LU2097828631.EUR","LU0359202008.SGD","LU0405327148.USD","BK0239","01276","BK0183","LU2328871848.SGD","LU1023057109.AUD","BK0012","LU1255011170.USD","LU1997245177.USD","LU1997245094.SGD","LU2148510915.USD","LU2495084118.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182415432","title":"HENGRUI PHARMA's Subsidiary Secures Approval for Clinical Trial Initiation","url":"https://stock-news.laohu8.com/highlight/detail?id=1182415432","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182415432?lang=en_us&edition=fundamental","pubTime":"2026-08-04 17:42","pubTimestamp":1785836575,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd. (600276.SH) has announced that its subsidiaries, Suzhou Shengdiya Biopharmaceutical Co., Ltd. and Shanghai Shengdi Pharmaceutical Co., Ltd., have received...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828557.USD","BK0060","BK1191","BK0028","IBBJ","LU2097828474.EUR","IBBQ","LU1820825898.SGD","LU1997245094.SGD","LU1255011170.USD","BK0183","LU1969619763.USD","PSYK","LU2543165471.USD","LU2289578879.USD","LU2580892789.USD","LU1781817850.SGD","LU2488822045.USD","LU0405327148.USD","LU1580142542.USD","LU1146622755.USD","BK0188","LU0359202008.SGD","LU1997245177.USD","LU1655091616.SGD","LU1997244956.HKD","LU2097828805.USD","600276","LU2148510915.USD","BK0196","01276","LU0359201612.USD","LU0405327494.USD","LU2097828714.EUR","MDTX","LU2097828631.EUR","LU1023057109.AUD","BK0239","LU1064131003.USD","LU1064130708.USD","BK0012","LU2495084118.USD","LU2580892862.HKD","LU2328871848.SGD","LU0359201885.HKD","LU1328615791.USD","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180518253","title":"Hengrui Pharma Maintains Stable H-Share Base; Repurchases 0.28 Million A-Shares in July","url":"https://stock-news.laohu8.com/highlight/detail?id=1180518253","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180518253?lang=en_us&edition=fundamental","pubTime":"2026-08-04 16:24","pubTimestamp":1785831869,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) filed its Monthly Return for Equity Issuer for July 2026 with Hong Kong Exchanges and Clearing Ltd. on 4 August 2026. Key takeaways are as...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171483922","title":"Dual-Listed Stock Premium Snapshot: August 3 Market Close","url":"https://stock-news.laohu8.com/highlight/detail?id=1171483922","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171483922?lang=en_us&edition=fundamental","pubTime":"2026-08-03 16:21","pubTimestamp":1785745307,"startTime":"0","endTime":"0","summary":" According to data as of the close on August 3, NE Electric (00042), Zhejiang Shibao (01057), and Sinopec SSC (01033) recorded the highest A-H premium ratios, with premiums of 988.71%, 348.22%, and...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B031J352.USD","LU0898667661.SGD","LU0516422440.USD","BK1522","LU1303224171.USD","BK1144","SG9999001903.USD","BK1184","LU0784639295.USD","LU0880133367.SGD","LU0348766576.USD","LU1282648689.USD","BK1231","LU1115378108.SGD","LU0979878070.USD","LU1880383440.USD","03750","BK1551","BK1610","LU0327786744.USD","00300","LU1282649067.USD","BK1558","LU0819121731.USD","LU0326950275.SGD","LU1282649141.HKD","LU1366334651.USD","SG9999002828.SGD","SG9999001093.SGD","LU0106252389.USD","IE0034224299.USD","LU0890818403.SGD","LU2153591404.USD","BK1122","LU0359201612.USD","02359","PAImain","LU0149534421.HKD","LU0011963245.USD","BK1523","BK1140","LU0039217434.USD","LU0588546209.SGD","BK1513","02691","LU0320764755.SGD","LU0918141887.USD","LU0821914370.USD","LU0348767384.USD","LU0229945570.USD","LU1242518931.SGD","03968","LU0029875118.USD","BK1141","LU0348825331.USD","LU0315178854.USD","LU0048580855.USD","LU0417516902.SGD","601318","LU0214875030.USD","LU0516422952.EUR","LU0831103253.SGD","BK1170","LU0348816934.USD","LU0370786039.SGD","BK1554","LU2242644610.SGD","BK1110","IE00B29SXG58.USD","LU0051755006.USD","BK1154","LU0417516738.SGD","BK1205","LU0588545730.USD","LU0823040885.USD","BK1147","LU0348814723.USD","LU0516423091.SGD","BK1562","IE00BYV24P56.USD","03200","BK1576","LU0762542818.HKD","LU0797268264.HKD","LU0181495838.USD","LU0868486357.SGD","LU0348784397.USD","HK0000252152.HKD","03308","HK0000286598.CNH","LU2424517915.HKD","LU0254981946.USD","HK0001040168.HKD","SG9999000459.SGD","LU1282651048.USD","BK1506","LU0043850808.USD","LU0611395673.USD","PNGAY","LU0878004406.USD","LU0675040207.SGD","IE00B5MMRT66.SGD","IE0008368742.USD","LU1051768304.USD","IE00BGHQDM52.EUR","HK0000320223.HKD","LU0501845795.SGD","LU0828237940.HKD","LU0648948544.HKD","LU1961090484.USD","LU2348773727.SGD","LU0348735423.USD","LU1675838814.USD","LU0634319403.HKD","LU0594300179.USD","00553","LU0463099449.HKD","LU0531970944.HKD","HK0000306701.USD","IE00BZ08YT58.USD","IE00B031HY20.USD","LU0502904849.HKD","LU0117844026.USD","LU0359202008.SGD","LU0540923850.HKD","LU0918141705.HKD","02318","LU0561508036.HKD","01635","IE00BZ08YS42.EUR","LU0456846285.SGD","LU0878005551.USD","SG9999002562.SGD","LU0737861699.HKD","LU1044876610.USD","LU0196878994.USD","LU1769817096.USD","00187","HK0000320264.USD","LU0117841782.USD","LU0210527791.USD","HK0000151867.HKD","LU0328353924.USD","IE00BZ08YR35.GBP","LU0149721374.USD","00042","01688","BK1163","BK1533","BK1125","LU1807302812.USD","LU0828237510.HKD","LU0417516571.SGD","BK1552","LU0588545904.SGD","LU0762540952.USD","LU0650527681.SGD","EWH","HPAD.SI","LU0572944931.SGD","LU1105468828.SGD","LU0640798160.USD","00895","LU0531971595.HKD","LU0164872284.USD","SG9999002463.SGD","BK1583","BK1135","00916","SG9999014674.SGD","LU0084288322.USD","HK0001040143.USD","LU1244550577.SGD","HK0000352291.HKD","LU1366334578.USD","LU0244354667.USD","BK1240","LU0882747503.HKD","LU0140636845.USD","LU0128522157.USD","LU0054450605.USD","BK1529","LU0543330566.HKD","399300","LU0067412154.USD","03145","LU0287142896.SGD","LU2039709279.SGD","BK1530","BK1521","LU0348805143.USD","LU2045819591.USD","LU0762541174.USD","02338","LU0543330483.HKD","LU0862451753.SGD","LU0431992006.USD","LU2399975544.HKD","06869","BK1171","01349","LU0164880469.USD","LU0856984785.SGD","LU0605514214.HKD","02768","LU1244550494.USD","BK1526","LU0072913022.USD","LU0231483743.USD","LU0488056044.USD","LU0588545490.SGD","LU0072462343.USD","LU1642822792.SGD","SG9999004220.SGD","01108","02715","06127","IE00BF5LJ272.USD","IE00BVYPNP33.GBP","LU2543165471.USD","LU0441854154.USD","BK1249","LU0593848301.USD","BK1537","LU1224709979.USD","BK1607","LU0865486749.SGD","LU1769817179.HKD","LU1515016050.SGD","LU0359201885.HKD","HK0000252160.HKD","LU0173614495.USD","LU1880383366.USD","06613","BK1202","LU0630378692.HKD","LU0348783662.USD","LU1282651121.HKD","00763","HK0000352382.USD","LU0449515922.USD","LU1960683339.HKD","00991","IE0032431581.USD","BK1183","LU1224444064.USD","02465","LU0455707207.USD","LU0197773673.USD","LU0165289439.USD","LU0348827113.USD","BK1191","LU1655091459.SGD","LU0293314216.USD","LU1981816686.USD","LU1808992512.USD","IE0008369823.USD","LU1152091168.USD","LU2226246903.HKD","LU0197773160.USD","SG9999011746.SGD","LU0589944569.HKD","01057","IE00BMCWC346.EUR","LU1235295612.USD","LU0049112450.USD","LU0607220059.USD","LU0164865239.USD","01812","BK1546","LU1481107354.HKD","LU0163747925.USD","HK0000306685.HKD","LU0348788117.USD","LU0831093199.SGD","LU0320764599.SGD","LU1044875133.USD","BK1149","03986","LU1226287529.USD","SG9999006597.SGD","HK0000500386.USD","LU0708995583.HKD","BK1514","IE00B543WZ88.USD","LU1146622755.USD","BK1507","LU2125910500.SGD","LU0106959298.USD","LU1719994722.HKD","LU1251922891.USD","01033","BK1550","SG9999001226.SGD","LU1046422090.SGD","LU1794554557.SGD","BK1560","LU0516422366.SGD","BK1594","LU0456827905.SGD","LU1244550221.USD","LU2476274308.USD","82318","LU0235996351.USD","LU2293587155.HKD","LU2778985437.USD","LU2348774022.SGD","IE00B0169L03.USD","BK1214","LU0630378429.USD","LU2152927971.USD","LU0315179316.USD","LU0791590937.USD","LU1328277881.USD","IE0003895053.USD","LU0862451837.USD","LU0651947912.USD","LU0516423174.USD","LU1813983027.USD","LU0672654166.SGD","LU0211977185.USD","02208","LU0307460666.USD","LU0823426308.USD","LU0314109678.HKD","BK1223","LU0052750758.USD","LU0469268626.HKD","LU1688375341.USD","LU1188198961.HKD","LU1044874839.SGD","BK1564","01276","LU0594300419.USD","LU1831875114.USD","LU0348783233.USD","LU0384037296.USD","03143","LU0823426480.USD","LU1051769294.HKD","00638","03328","LU2153592121.USD","06655","LU1770034418.SGD","LU0651946864.USD","06680","IE00B3M56506.USD","IE00BVYPNQ40.USD","BK1221","LU0449509016.USD","LU1048596156.SGD","LU1211504680.USD","IE0031814852.USD","LU0819123356.HKD","BK1105","LU2294711473.HKD","LU1152091754.HKD","LU1048588211.SGD","LU1282649810.SGD","159982","LU0210526637.USD","LU0049853897.USD","LU1820825898.SGD","LU1023057109.AUD","LU1008478684.HKD","LU1993786604.SGD","LU0228367735.SGD","LU0228659784.USD","LU1720050803.USD","LU0871576103.HKD","LU0791591158.USD","LU2476274720.SGD","03678","LU1242518857.USD","BK1116"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656289563","title":"Metis TechBio Jumps on Jiangsu Hengrui-tie up on AI Formulation Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2656289563","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656289563?lang=en_us&edition=fundamental","pubTime":"2026-08-03 13:48","pubTimestamp":1785736133,"startTime":"0","endTime":"0","summary":"BUZZ-Metis TechBio jumps on Jiangsu Hengrui-tie up on AI formulation platform** Shares of Metis TechBio7666.HKjump 9.3% in the second rising session to HK$11, their highest level since July 28** Stock","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL1N44004N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0196","BK0188","LU0405327494.USD","LU2097828557.USD","LU2289578879.USD","LU1064130708.USD","BK0239","LU1146622755.USD","BK0060","BK0183","LU1655091616.SGD","LU2488822045.USD","LU0359202008.SGD","BK1191","LU2097828474.EUR","LU2543165471.USD","LU1023057109.AUD","LU1580142542.USD","LU2328871848.SGD","LU1997245177.USD","BK1161","LU2097828714.EUR","BK0028","01276","LU1997245094.SGD","LU1328615791.USD","LU2580892862.HKD","LU2148510915.USD","LU1064131003.USD","BK0012","LU1969619763.USD","LU1820825898.SGD","600276","LU0359201612.USD","LU2097828805.USD","LU0405327148.USD","LU2580892789.USD","07666","LU1781817850.SGD","LU1997244956.HKD","LU1255011170.USD","LU0359201885.HKD","LU2495084118.USD","LU2097828631.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103059933","title":"METIS TECHBIO-P Deploys AI Drug Formulation Platform at HENGRUI PHARMA, Accelerating NanoForge Commercialization","url":"https://stock-news.laohu8.com/highlight/detail?id=1103059933","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103059933?lang=en_us&edition=fundamental","pubTime":"2026-08-03 12:20","pubTimestamp":1785730837,"startTime":"0","endTime":"0","summary":"On August 3, METIS TECHBIO-P (07666) announced that its self-developed AiTEM AI drug formulation innovation platform will be locally deployed at HENGRUI PHARMA (600276.SH, 01276) to enhance drug...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","LU1997245177.USD","VTHR","LU1023057109.AUD","BK0028","BK0183","LU1820825898.SGD","LU1997245094.SGD","BK1191","LU2495084118.USD","LU2289578879.USD","LU1997244956.HKD","LU0405327494.USD","LU2097828474.EUR","LU1580142542.USD","07666","CHAT","LU2580892862.HKD","600276","LU0359202008.SGD","LU1655091616.SGD","LU2488822045.USD","LU0359201612.USD","BK0188","BK0196","AIPO","LU1064130708.USD","QTOC","LU1328615791.USD","01276","LU1146622755.USD","LU2543165471.USD","LU1255011170.USD","BK1161","BK0012","LU2580892789.USD","AGIX","LU1064131003.USD","LU2148510915.USD","ARTY","LU2328871848.SGD","LU2097828557.USD","LU2097828805.USD","LU2097828714.EUR","LU0359201885.HKD","LU0405327148.USD","LU1969619763.USD","LU2097828631.EUR","LU1781817850.SGD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189253393","title":"The Capital Group Companies Increases Stake in Hengrui Pharma with 483,600 Share Purchase at Approximately HK$57.90 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=1189253393","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189253393?lang=en_us&edition=fundamental","pubTime":"2026-08-03 08:20","pubTimestamp":1785716442,"startTime":"0","endTime":"0","summary":"The Hong Kong Stock Exchange's latest filings reveal that on July 29, The Capital Group Companies, Inc. added to its position in HENGRUI PHARMA (01276) by acquiring 483,600 shares.The transaction was...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828557.USD","LU1655091616.SGD","LU1997245177.USD","LU1781817850.SGD","LU0405327494.USD","LU0359201885.HKD","BK0196","BK0239","LU0359202008.SGD","BK0188","LU2097828631.EUR","LU2488822045.USD","LU1820825898.SGD","LU2097828714.EUR","LU2495084118.USD","LU2289578879.USD","600276","BK0183","LU0359201612.USD","LU1064130708.USD","EWH","LU2580892862.HKD","BK0028","LU1997245094.SGD","LU1023057109.AUD","BK1191","BK0012","LU2097828474.EUR","LU1255011170.USD","LU1328615791.USD","LU1969619763.USD","LU1146622755.USD","LU1997244956.HKD","LU2097828805.USD","LU0405327148.USD","LU2328871848.SGD","LU2148510915.USD","LU2543165471.USD","01276","LU2580892789.USD","LU1064131003.USD","LU1580142542.USD","BK0060"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}